Kobo Biotech Reports Delay in Resolution Plan Implementation by Beaufond Industries Limited
Kobo Biotech Limited has announced that the implementation of the approved resolution plan remains incomplete. The Successful Resolution Applicant, Beaufond Industries Limited, has not fulfilled the terms and timelines stipulated under the plan as of July 14, 2026.The National Company Law Tribunal (NCLT), Hyderabad Bench, issued an order on May 11, 2026, approving the resolution plan submitted by Beaufond Industries Limited for the company. Under the terms of this approved plan, the implementation was required to be finished within 60 days from the date of approval.
The following table outlines the key dates associated with the resolution plan:
| Event | Date |
|---|---|
| NCLT Approval of Resolution Plan | May 11, 2026 |
| Completion Deadline | July 10, 2026 |
| Current Reporting Date | July 14, 2026 |
Due to the failure to complete the implementation within the required timeframe, the company is convening a meeting of the Monitoring Committee. This meeting will be held to deliberate on the current status of the resolution plan implementation and to determine the further course of action regarding the matter.
Stock Price Movement
As of 10:14, Kobo Biotech Ltd-$ shares are ticking up to ₹9.82, representing a 1.97% gain for the day. The stock is currently trading completely flat as it remains locked at both its intraday high and low of ₹9.82.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.